Happening tomorrow: Get your glaucoma questions answered. Dr. Poonam Misra of Manhattan Eye, Ear & Throat Hospital joins our Glaucoma Chat at 1 p.m. ET for a live conversation. She’ll cover frequently asked questions about glaucoma. Listen live tomorrow: https://bit.ly/4nz3KGw

When Dave Palmer's father lost vision to age-related macular degeneration, Dave and his wife Leanna wanted to help. They started supporting Macular Degeneration Research at BrightFocus Foundation. See the impact of donor support in our 2025 annual report: https://bit.ly/4o6LuFF.

A surprising connection: Parkinson's drug L-DOPA protects against age-related macular degeneration (AMD). Researcher Brian McKay, PhD, used this finding to discover a protective eye pathway & create an AMD supplement. Now he's working on new treatments based on this discovery. 🔬

Join us for our next Glaucoma Chat on Nov. 12 at 1 pm ET, featuring Dr. Poonam Misra, a glaucoma specialist & fellowship co-director at Manhattan Eye, Ear & Throat Hospital, who'll address some of the most common questions listeners have shared over the past year. Register: https://bit.ly/3WDDLTn

"If you can't help the one you love, help the one you can." When the Sahyun family faced both vision loss & dementia diagnoses, this advice transformed their heartbreak into hope. Read about how they—and other families—are fueling Alzheimer’s research in our annual report: https://bit.ly/4ovA8L6

Join our Macular Chat tomorrow, October 29, with Dr. Jeffrey Stern, co-founder of the Neural Stem Cell Institute. He'll cover the latest science, share clinical trial updates, and explain what these advances mean for people living with AMD. Listen live. 🔊 ↘️

🧠 New infographic: FDA-approved Alzheimer's treatments at a glance—how they work, administration methods, and which disease stages they target. View it here: https://bit.ly/42Ziuaq Made possible by sponsorships from Eisai and Lilly.

🧠 Did you know your gut health could impact your Alzheimer's risk? Join Dr. Beau Ances from @WashU today (Oct 21) at 1 p.m. ET as he breaks down the emerging science connecting trillions of gut bacteria to brain health. Watch live and get your questions answered. ⤵️

New research is exploring how to restore vision after glaucoma damage. Dr. Lucy Q. Shen breaks down the science and shares what makes her hopeful about the future of treatment. 🔊 Listen here: https://bit.ly/47aaLau #GlaucomaChat #Glaucoma #BrightFocusFoundation

Could gut bacteria affect your brain? 🧠🦠 Join Dr. Beau Ances Oct 21 at 1 p.m. ET to explore the gut-Alzheimer's connection and learn steps to support both gut and brain health. Register at: https://bit.ly/4qhsHsO #Alzheimers #BrightFocusFoundation #ZoomInAlz

Thanks to donor support, we're funding bold projects like Dr. Joe Herdy's—exploring how genetics and inflammation intersect in Alzheimer's disease. Together, we’re building a future with better treatments and more hope. 💙 Discover his story: https://bit.ly/46QVIUq

🔬 Research into macular degeneration is advancing fast—from earlier detection to new treatments. Drs. Bovenkamp and Rossi discuss the projects making an impact and where the field is headed next. Listen to our full Macular Chat: https://bit.ly/3JaiRrH

Electronic implants in the retina or brain can restore partial vision in people who have lost the light-sensing cells in their eyes. This technology is offering hope to those with severe vision loss due to diseases like age-related macular degeneration (AMD). Learn more: https://bit.ly/3KUJr8J

🔬 Restoring vision with eye transplants has long been out of reach—but BrightFocus-funded research is changing that. Dr. Jason Meyer's work may not only help restore sight lost to glaucoma, but could reshape what we thought possible in vision science. Find out more. ⤵️

That's a wrap on Glaucoma Fast Track 2025! Researchers from around the world gathered in Atlanta to learn from experts, present their work & build networks that will drive glaucoma research forward. Breakthroughs happen when talented researchers get the mentorship, resources & community they need.

Team BrightFocus Foundation is on the ground in Atlanta for our #GlaucomaFastTrack program, the official pre-symposium workshop to the ISER/BrightFocus Glaucoma Symposium. Glaucoma Fast Track brings together top researchers from across the globe to accelerate vision research. 💪 🔬

Tune in today (Oct 8) for our next Glaucoma Chat featuring Dr. Astrid Werner to learn what causes dry eye, how to recognize the symptoms, and effective treatment options—including preservative-free drops, artificial tears, and eyelid care routines. 🔊 Listen live: https://bit.ly/3KzA0eK.

Join us for our next Glaucoma Chat on Wednesday, Oct 8, featuring Dr. Astrid Werner to learn what causes dry eye, how to recognize the symptoms, and effective treatment options—including preservative-free drops, artificial tears, and eyelid care routines. Register today: https://bit.ly/46v9zQ2.

Tune in to tomorrow's episode of Zoom In on Dementia & Alzheimer’s. Dr. Laura Baker will share results from the U.S. POINTER trial—the largest study of its kind to test how lifestyle changes impact brain health: https://www.youtube.com/live/eh7EwYm11zY

📢 Our 2025 annual report is here! Thanks to donors, BrightFocus Foundation funded 186 research grants in 16 countries advancing the fight against Alzheimer's, macular degeneration & glaucoma. Read the full report: https://bit.ly/4nD6rrp

Can your lifestyle choices protect your memory? New findings from the U.S. POINTER trial suggest they can. Join us on Oct 2 to learn how combining key lifestyle strategies could be your best defense against dementia. Register: https://bit.ly/4pHZNle

Can doctor's slow geographic atrophy progression? Retina specialist Dr. Sara Fard has answers. Join our Macular Chat tomorrow (Sept. 24) at 1 p.m. ET. Listen live 🔊 https://bit.ly/46cyZlj

📢 BrightFocus Foundation is proud to welcome Jimmy Liu, PhD, as our new Director of Vision Science Programs! Dr. Liu brings deep expertise in eye disease research and a passion for advancing the next generation of treatments for macular degeneration and glaucoma. Read more: https://bit.ly/4mjop0x

Join us for our Sept 24 Macular Chat featuring Dr. Sara Fard, a retina specialist at Illinois Retina Associates, as she explains the benefits of sustained GA treatment, including slowing the rate of vision loss, protecting retinal tissue & supporting visual function. Details: https://bit.ly/4miH393

Glaucoma affects more than 4 million Americans & can only be diagnosed through a dilated eye exam—yet too many people don’t know they have glaucoma until irreversible vision loss has occurred. Our new "Stop Glaucoma” PSA encourages everyone to protect their sight: https://bit.ly/46q9jQS

Age-related macular degeneration (AMD) affects millions and can only be diagnosed through eye exams. Many don't know they have it until irreversible vision loss has already occurred. Watch our new PSA featuring first-person accounts of vision loss. Join us to #StopAMD: https://bit.ly/4na8QK1

Dr. Keith Hengen is taking a new approach to Alzheimer's research by studying early brain activity patterns during sleep. Join us on Sept 18 at noon ET on Instagram Live for a conversation about his Alzheimer's research + answers to your questions. Read more: https://bit.ly/3Kme46I.

Despite high risk, people with Down Syndrome are excluded from Alzheimer's trials. Inclusive research will increase their life expectancy by 5 years & reduce care costs. Read about the research co-funded by BrightFocus Foundation and published in @alzdemjournals.bsky.social: https://bit.ly/42rTojT

Attention scientists: Join BrightFocus Foundation for #AlzFastTrack—an official pre-meeting for #SfN25. ⌛ Registration closes Sept 15, 2025! Learn from experts in the Alzheimer’s and dementia field, network, and grow your grant writing skills. Register: https://bit.ly/4gcAMtQ

What if vision loss from glaucoma could be restored? Find out today at 1pm ET, when Dr. Lucy Shen of Mass. Eye and Ear breaks down where the science stands on vision restoration. Watch our livestream to learn about the latest advances in optic nerve regeneration and stem cell and gene therapies. ⤵️

A treatment being tested in clinical trials for mild-to-moderate Alzheimer's using personalized, non-invasive brain stimulation shows promise in slowing cognitive decline and preserving daily function. Read about Dr. Giacomo Koch's research: https://bit.ly/41Jr4JG 🧠 🔬

Dr. Roberta Diaz Brinton from the @uazhealthsciences.bsky.social discusses the ReGenBRAIN clinical trial and the potential for harnessing the brain's natural growth processes for the treatment of Alzheimer’s. Learn more & watch our full episode: https://bit.ly/3JQKxSw #Science #Health #Alzheimers

The connection between sugar and age-related macular degeneration is stronger than you might think. Research indicates that high-glycemic foods like soda, candy, white bread, and pasta create inflammatory compounds that can harm your retina. Read more: https://bit.ly/465PeiL.

We're hosting an Instagram Live on Sept 18 at 12 pm ET with Dr. Sharyn Rossi, senior director neuroscience at BrightFocus Foundation & Dr. Keith Hengen of @uwdeptmedicine.bsky.social. We'll cover sleep and brain health, new research & answer your questions live on Instagram. Set your reminder. 🔔

Join us for an update on the HOPE Study, which is testing whether non-invasive 40 Hz light and sound stimulation can slow Alzheimer’s. We’ll explore what the science shows so far and take your questions about this and other non-invasive dementia treatments. Register now: https://bit.ly/3HZvJR0.

📢 #BreakingNews: The FDA has approved an at-home version of Leqembi, the first anti-amyloid therapy individuals can self-administer with a weekly injection. This new option makes treatment more convenient for families & continues to target harmful brain plaques that drive Alzheimer’s. Read more. ⤵️

A next-generation blood test could personalize Alzheimer's treatment by revealing disease progression—not just diagnosis. BrightFocus Foundation grant recipient, Dr. Gemma Salvadó, helped validate this test to identify ideal candidates for anti-amyloid therapies. 🔬 Full story ⬇️

Join us live TODAY at 1 p.m. ET for a conversation with BrightFocus Foundation Scientific Affairs teammates Dr. Diane Bovenkamp and Dr. Sharyn Rossi as they discuss this year's Macular Degeneration Research bold and innovative projects. To tune in, visit: https://bit.ly/4mAxIdG.

Join us for a 1-hour panel discussion with leaders in the fight against Alzheimer's. This conversation is inspired by Taking Care, a documentary following the journey of Seth Rogen and Lauren Miller Rogen as they navigate Lauren's mother's advancing Alzheimer's. Register: https://bit.ly/4lH7bdc

BrightFocus Foundation recently awarded $3.8 million to researchers advancing bold ideas to understand, prevent, and treat macular degeneration worldwide. Join @dianebovenkamp.bsky.social and Sharyn Rossi, PhD as they discuss this year's innovative projects. Live on 8/27 at 1 pm ET: bit.ly/3UBbzj0

BrightFocus Alzheimer’s Disease Research-funded scientists are developing a home-based brain stimulation treatment that targets memory & mood—all without medication. Learn how this bold new approach could improve quality of life for people living with Alzheimer’s & their families: bit.ly/47xlAFp.

Mengya Zhao, PhD, a BrightFocus National Glaucoma Research grant recipient, uses innovative models to study neuronal resilience to glaucoma. Her findings could reveal survival signals in resistant retinal ganglion cells & guide therapies to protect more sensitive ones. Read more: bit.ly/4m3YdaT 🔬

Think it’s just aging? Why dementia is missed for 3.5 years on average ucl.ac.uk/news/2025/ju... via @ucl.ac.uk #Alzheimers #dementia #health #wellness

Dr. Sandeep Moothedath Subrahmanian of Penn State College of Medicine is studying how a “molecular switch” causes a stress response protein, REDD1, to build up and damage retinal cells in early macular degeneration. His goal: to stop the disease before vision is lost. Read more: bit.ly/47jUpxN

From lifestyle changes that protect memory and cutting-edge blood tests to evidence that past lead exposure can impact brain health decades later—major findings at #AAIC2025 are shaping the future of Alzheimer's prevention, diagnosis, and care. Learn more: bit.ly/3HhDLnO

Join Dr. Amy Zhang from the University of Michigan Kellogg Eye Center on Aug 13 at 1pm ET to discover why proactive glaucoma care matters. We'll discuss cutting-edge options like minimally invasive surgery, at-home pressure monitoring, and continuous drug delivery systems. Learn more. ⬇️

Meet our newest grant recipients across Alzheimer’s, macular degeneration & glaucoma research! These exceptional investigators were selected for their potential to bring us closer to cures by pursuing the untried, the unexpected, and the most promising ideas. Explore their research: bit.ly/4mnqZTX

Day 1 at #AAIC25! Medlive's Vandana Gupta, MSc shared our poster outcomes with Brooks Kenny of @brightfocus.bsky.social, Dustin Gad of @cornelluniversity.bsky.social, Erin Beck of SiteRx, Rebecca Elliot & Julie Wood of @aafp.org, & many other #neurology and #AlzheimersCare leaders. 🔗 bit.ly/41iBNdF

Don’t miss this @ismnd.bsky.social webinar on Monday, August 11 at 10 am Eastern! I’ll be moderating discussions on a highly anticipated presentation by Dr. @petetheteapot.bsky.social Pete Williams, who is a fresh FY25 @brightfocus.bsky.social National Glaucoma Research grantee! See you there.

Live from #AAIC25 in Toronto! Our team is connecting with partners, community advocates, and leading Alzheimer's researchers—including many of our funded scientists. Every connection brings us closer to a #MindSightCure. 🧠 🔬 💪